Search

everythinglearnresearchcommunity

for

Search:↓

P144® improves hypertrophic scars by reducing size and thickness and increasing elasticity.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

PRP therapy helps skin heal and improve by promoting cell growth and repair.

Cannabidiol shows promise as an effective treatment for acne.

Deleting the EDAR gene in Cashmere goats affects genes and proteins related to hair growth.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Psychological stress and personal history are significant factors in hair loss.

Treg cells help repair and regenerate tissues by interacting with local cells.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Teratoma hair is similar to scalp hair but has a rougher surface and lower adhesive force.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Ayurvedic treatment, exercise, and a healthy diet can effectively manage PCOD symptoms.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.